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Abstract
Background:  Non-typhoidal  Salmonella  (NTS) is increasingly recognized as an important pathogen
associated with bacteraemia especially in immunosuppressed patients. However, there is limited data
specifically describing the clinical characteristics and outcome amongst the immunosuppressed patients.
Methods: A total of 56,707 blood culture samples and 5,450 stool samples were received by the
microbiology laboratory at a tertiary referral hospital in Malaysia, during a 4-year study period. Out of
these samples, 55 non-duplicate NTS isolates were identified from blood and 121 from stool. A
retrospective analysis of the 55 patients with NTS bacteraemia was then conducted to determine the
predominant NTS serovars causing bacteraemia and its' blood invasive potential, epidemiological data,
clinical characteristics and antimicrobial susceptibility. Patients were then grouped as immunosuppressed
and non-immunosuppressed to determine the association of severe immunosuppression on clinical
features. Data was analyzed using the Statistical Package for Social Sciences (SPSS version 15.0) using the
non-parametric Mann-Whitney test, Fisher's exact test or Chi-squared test. The odds ratio (OR) and its
95% confidence intervals (CI) were calculated. The P-value < 0.05 (two-tailed) was taken as the level of
significance.
Results: Out of 55 NTS bacteraemia cases identified, 81.8% (45/55) were community-acquired. Salmonella
enterica serovar Enteritidis had the highest blood invasiveness. An extra-intestinal focus of infection was
noted in 30.9% (17/55) of the patients, most commonly involving the lungs and soft tissue. 90.9% (50/55)
of the patients had an underlying disease and 65.5% (36/55) of the patients had severe clinical
immunosuppressive condition with malignancy and HIV being the most common. Immunosuppressed
patients had higher mortality (P = 0.04), presented more commonly with primary bacteraemia (P = 0.023),
leukopenia (P = 0.001) and opportunistic infections (P = 0.01). In contrast, atherosclerotic conditions (P
= 0.015), mycotic aneurysms (0.037) and gastroenteritis (P = 0.03), were significantly more common in the
non-immunosuppressed patients. The non-immunosuppressed group also had a higher proportion of older
patients (>50 years) with a significantly higher median age (64 versus 36.5 years; p = 0.005).
Conclusion: Patients with severe clinical immunosuppression had higher mortality, presented more
commonly with primary bacteraemia, leukopenia and opportunistic infections and absence of
gastroenteritis. Early identification and prompt medical treatment can be life saving because of the high
mortality and morbidity associated with this disease especially in the immunosuppressed patients.
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Background
Non-typhoidal  Salmonella  (NTS) species are important
food borne pathogens with acute gastroenteritis being the
most common clinical manifestation. However, invasion
beyond the gastrointestinal tract occurs in approximately
5% of the patients with NTS gastroenteritis resulting in
bacteraemia [1]. Certain serovars of Salmonella  show a
much higher predilection for causing bacteraemia and
these serovars differ in different countries [2,3]. As a larger
proportion of patients have become immunocompro-
mised either due to certain primary diseases or modern
aggressive therapies, the occurrence of NTS invasive dis-
ease appears to be increasing [4]. Although NTS infections
have been widely studied in medical literature, few studies
have focused specifically on NTS bacteraemia. Moreover,
data specifically describing the epidemiological and clini-
cal characteristics amongst the immunosuppressed
patients is scarce.
Therefore, this study was undertaken to determine the a)
blood invasive potential and the predominant NTS serov-
ars causing bacteraemia in a tertiary hospital in Malaysia
b) clinical characteristics and risk factors associated with
NTS bacteraemia c) effects of severe immunosuppression
on clinical presentation and outcome.
Methods
Study design and selection of patients
A retrospective study was performed from July 2002 till
July 2006 involving patients admitted at Penang General
Hospital, a 1100-bedded Malaysian hospital that func-
tions as a tertiary referral hospital for many disciplines
including haematology, oncology, rheumatology and
infectious diseases as well as serving the local population.
A total of 56,707 blood samples and 5,450 stool samples
were received and processed at the microbiology labora-
tory during the study period. The clinical notes of the 55
patients identified to have NTS bacteraemia were
reviewed retrospectively. For patients with recurrent NTS
isolated from blood and stool, only the first episode was
included for analysis. The following data was obtained
from patients with NTS bacteraemia: demographic charac-
teristics, clinical manifestations, possible predisposing
factors, antibiotic susceptibilities, treatment and clinical
outcome. Relevant data from the 121 non-duplicate NTS
isolated from stool was obtained from the microbiologi-
cal records to determine the 'blood invasiveness ratio'
(BIR).
Case definition
BIR reflects the blood invasion potential of a particular
NTS serovar and is calculated as the ratio of blood isolates
(B) to the total number of blood and stool isolates (T) for
each Salmonella serovar (B/T ratio) and expressed per 100
blood+stool isolates [5]. An extra-intestinal focus of infec-
tion (EFI) was defined as the presence of clinical or radio-
logical evidence of infection supported by isolation of
NTS from a site other than stool specimen. Bacteraemia
was classified as primary or secondary according to the
classification proposed by Ramos JM et al. [6], with some
modification. Primary bacteraemia was diagnosed when
NTS was isolated from one or more blood cultures with
no isolation from other infected foci and no history of
recent gastroenteritis. The term secondary bacteraemia
was used when isolation of NTS from blood followed an
episode of gastroenteritis and if Salmonella was not iso-
lated from any source except stool.
Community-acquired bacteraemia was defined as bacter-
aemia that develops in a patient prior to admission, or a
positive blood culture obtained within 48 hours of hospi-
tal admission, in patients without history of hospitaliza-
tion in the 2 weeks prior to the current bacteraemic
episode. The infection was considered hospital-acquired if
it developed 48 hours or later after admission.
Paediatric population was defined as patients aged 16
years or less. Patients were considered to have severe clin-
ical immunosuppression when any of the following con-
ditions were present; human immunodeficiency virus
(HIV) infection, use of immunosuppressive therapy, neu-
tropenia (absolute neutrophil count < 500/mm3), malig-
nancy or autoimmune disease. Immunosuppressive
therapy included recipients of corticosteroids (at least 10
mg of prednisolone/day or equivalent corticosteroids) or
chemotherapy for malignancy received within 2 weeks
prior to bacteraemia. Atherosclerotic conditions were
defined as having atherosclerotic diseases or risk factors
for atherosclerosis (previous ischaemic stroke, ischaemic
heart disease, diabetes mellitus and hypertension).
Shock was defined as systolic blood pressure ≤ 90 mm Hg
or an unstable hemodynamic status requiring inotropic
agents to maintain blood pressure and was considered
bacteraemia related if there was no other obvious reason
for it. Renal dysfunction was defined as a twofold increase
in baseline serum creatinine level or an increase in serum
creatinine level of 176.8 μmol/L (2.0 mg/dL), leukopenia
(<4 000 leukocytes/mm3) and leukocytosis (>11 000 leu-
kocytes/mm3). Antibiotic treatment was deemed ade-
quate if at least one antibiotic used within the first 72
hours of a positive blood culture had in-vitro activity
against the Salmonella strain isolated. Antibiotics consid-
ered potentially active included ampicillin and its' deriva-
tives (ampicillin-sulbactam, amoxicillin/clavulanate),
chloramphenicol, ceftriaxone, ciprofloxacin and cotri-
moxazole.Annals of Clinical Microbiology and Antimicrobials 2009, 8:15 http://www.ann-clinmicrob.com/content/8/1/15
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Microbiology
All blood cultures were processed using the Bactec 9240
fluorescent system (Becton Dickinson). All isolates were
identified as Salmonella according to standard microbio-
logical techniques [7]. Serotyping of all Salmonella isolates
was performed according to Kaufmann-White scheme
using O and H antisera (Difco) [8] either at the local
microbiology laboratory or at the regional public health
laboratory. Other laboratory data included antibiotic sus-
ceptibilities, time taken for BACTEC culture bottles to turn
positive and some haematology parameters. Antibiotic
susceptibility was determined by means of Kirby-Bauer
disk diffusion method using the guidelines provided by
Clinical Laboratory Standard Institute (CLSI), formerly
known as National Committee for Clinical Laboratory
Standards (NCCLS) guidelines [9]. The antimicrobial
agents routinely tested included ampicillin, chloram-
phenicol, trimethoprim-sulfamethoxazole, ciprofloxacin
and ceftriaxone.
Statistical analysis
Clinical data of all patients was obtained until discharge
or death. Statistical analysis was then performed to deter-
mine the association of severe immunosuppression on
clinical and epidemiological characteristics. Data was ana-
lyzed using the Statistical Package for Social Sciences
(SPSS version 15.0). Continuous variables were expressed
as median ± interquartile range (IQR) and comparison
was made using the non-parametric Mann-Whitney test.
Categorical variables were expressed as numbers and per-
centages and comparison amongst variables was deter-
mined by the Fisher's exact test or Chi-squared test. The
odds ratio (OR) and its 95% confidence intervals (CI)
were calculated. The P-value < 0.05 (two-tailed) was taken
as the level of significance.
Results
Serogroup and serovar distribution of NTS
A total number of 56,707 blood samples were received by
the microbiology laboratory for bacterial culture during
the study period, from which 6,015 (10.6%) samples were
positive for bacterial growth. Among the positive blood
samples, 55 non-duplicate NTS isolates were identified.
Similarly, a total number of 5,450 stool samples were
received for bacterial culture during this period, from
which significant stool pathogens were identified in 317
samples (5.8%). Non-duplicate NTS isolates were cul-
tured from 121 patients. The distribution of these NTS
isolates according to serovars and the 'blood invasiveness
ratio' (BIR) is presented in Table 1.
Demographic features
Male patients predominated (67.3%). No age group was
excluded, with the youngest patient being one year and 4
months and the oldest 89 years (median ± IQR, 39 ± 43
years). There were thirteen (23.6%) paediatric patients.
Majority of the patients were Malays (49%) followed by
Chinese (42%), Indians (7%) and others (2%).
Clinical characteristics and outcome
Fifty patients (90.9%) had at least one underlying disease
predisposing them to NTS bacteraemia. The predisposing
factors are illustrated in Table 2. In four patients, more
than one risk factors were identified; 2 patients with SLE
had renal failure requiring hemodialysis, 1 patient with
AIDS had liver cirrhosis due to hepatitis B and 1 patient
with carcinoma of pancreas had underlying ischaemic
heart disease.
Thirty-six patients (65.5%) had at least one severe clinical
immunosuppressive condition. Underlying malignancy
(23.6%) was the most common risk factor followed by
AIDS/HIV (20%). Eight patients with underlying malig-
nancy and 3 patients with SLE were on immunosuppres-
Table 1: Serovar distribution of NTS in blood and stool and its' blood invasive ratio (BIR)
Serovar Serogroup Blood isolates (%)
n = 55
Stool isolates (%)
n = 121
BIR*
Enteritidis D 40 (72.7) 19 (15.7) 67.8
Paratyphi b B 3 (5.5) 8 (6.6) 27.3
Choleraesuis C 1 (1.8) 3 (2.5) 25.0
Senflenberg E 1 (1.8) 3 (2.5) 25.0
Blegdam D 3 (5.5) 10 (8.3) 23.0
Tshiongwe C 2 (3.6) 8 (6.6) 20.0
Hato B 1 (1.8) 4 (3.3) 20.0
Corvallis C 4 (7.2) 23 (19.0) 14.8
Waltevreden E 0 (0.0) 14 (11.6) 0
Limete B 0 (0.0) 8 (6.6) 0
Typhimurium B 0 (0.0) 6 (5.0) 0
Others 0 (0.0) 15 (12.4) 0
* BIR = (B/T) × 100 (B = blood isolates and T = total blood+stool isolates)Annals of Clinical Microbiology and Antimicrobials 2009, 8:15 http://www.ann-clinmicrob.com/content/8/1/15
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sives. Majority of the cases (45/55, 81.8%) presented with
community-acquired bacteraemia. In one-fifth of the
cases, bacteraemia was hospital-acquired with a detection
time of 8 to 30 days after admission.
Seventeen patients (30.9%) had at least one extra-intesti-
nal focus of infection (EFI). In three cases, more than one
organ was involved. Lung and soft tissue were the most
common extra-intestinal sites involved. All the four soft
tissue infections had microbiological evidence of infec-
tion either from pus or tissue; two had soft tissue abscesses
(chest wall and pararenal), one had an infected bedsore
and one case had a highly unusual presentation of necro-
tizing fasciitis. Pneumonia was associated with isolation
of NTS from respiratory secretions and in one case it was
complicated by empyema, requiring chest tube drainage.
Of the three cases involving bone and joint, two had sep-
tic arthritis and one presented with an infected knee
implant. Three patients developed radiologically con-
firmed aortic mycotic aneurysm, out of which one case
was fatal. All three mycotic aneurysms occurred in
patients above 65 years of age and each had at least one
atherosclerotic condition, (diabetes mellitus in two
patients and ischaemic heart disease in one). Meningitis
was a feature in two children aged 2 and 3 years and a 39
years old male. NTS was isolated from cerebrospinal fluid
from all 3 cases. All three cases of meningitis had an
underlying risk factor (agammaglobulinaemia, thalassae-
mia and AIDS respectively) and one case was complicated
by subdural effusion. Bacteraemia was associated with
NTS urinary tract infection in two cases, both occurring in
males aged > 70 years with an associated benign prostatic
hyperplasia. Thirty-eight patients (69%) had bacteraemia
without any obvious EFIs.
Thirty-four patients (61.8%) received initial empiric anti-
biotic therapy that was appropriate for treatment of NTS
bacteraemia in the first 72 hours. Of these ampicillin and
its' derivatives (ampicillin/sulbactam and amoxicillin/cla-
vulanic) were administered to 11 patients; ceftriaxone
(17); ciprofloxacin (3); cefotaxime (2) and cotrimoxazole
(1).
The overall mortality rate was 21.8% (12 of 55). Among
patients who survived, the median (± IQR) duration of
hospitalization was 9 days (± 13).
Antibiotic susceptibility
The antibiotic resistance rates was highest with ampicillin
(30.9%), followed by trimethoprim-sulfamethoxazole
(18.2%). Ceftriaxone, ciprofloxacin and chloramphenicol
were fully susceptible in all the isolates.
Association of severe immunosuppression on 
epidemiological and clinical characteristics
Table 3 shows the comparison between patients with or
without severe immunosuppressive conditions. Primary
bacteraemia was significantly more common as a present-
ing feature in the immunosupressed patients compared to
the non-immunosuppressed. The immunosuppressed
group also had significantly higher mortality rates (11/36,
30.6%). Opportunistic infections were associated only
with the severely immunosuppressed group. Eight of the
eleven patients with HIV had concomitant opportunistic
infections (six had Mycobacterium tuberculosis and one
each had Penicillium marneffei and  Toxoplasma gondii).
Candidaemia was present in two patients with underlying
malignancy and one patient with SLE manifested with
tuberculosis.
Table 2: Clinical characteristics of patients with NTS 
bacteraemia
Characteristics No of cases (n = 55) %
Underlying condition
Severe immunosuppressive conditions * 36 65.5
Malignancy 13 23.6
Solid† 9
Haematological‡ 4
AIDS 11 20.0
SLE 6 10.9
Hypogammmaglobulinaemia 2 3.6
Immunosuppressives 15 27.3
Atherosclerotic conditions * 8 14.5
Hypertension 3 5.5
Diabetes mellitus 4 7.3
Ischaemic heart disease 2 3.6
Stroke 2 3.6
Liver cirrhosis§ 4 7.3
Renal disease 4 7.3
Others¶ 23 . 6
Sites of infection
Blood only 38 69.1
EFI** 17 30.9
Lung 4 7.3
Soft tissue 4 7.3
Bone and joint 3 5.5
Meningitis 3 5.5
Mycotic aneurysm 3 5.5
Urinary tract 2 3.6
Peritonitis 1 1.8
* A patient may have more than one conditions under these 
categories (severe immunosuppressive or atherosclerotic categories), 
therefore the total number of conditions may not tally with the main 
category
**A patient may have more than one EFIs
†Includes carcinoma rectum, pancreas, stomach, colon, liver, brain 
glioma, yolk sac tumor of lung, osteosarcoma, lymphoma
‡ Includes acute lymphoblastic leukaemia (n = 3), acute myeloid 
leukaemia (n = 1)
§Includes Hepatitis B (n = 2) alcoholic liver cirrhosis (n = 1), Hepatitis 
C (n = 1)
¶Includes travel from Pakistan (n = 1), Thalassaemia (n = 1)Annals of Clinical Microbiology and Antimicrobials 2009, 8:15 http://www.ann-clinmicrob.com/content/8/1/15
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Overall, fifteen patients presented with leukopenia
(27.3%) and thirteen with leukocytosis (23.6%). Patients
with severe immunosuppression had a higher proportion
of leukopenia and significantly lower leukocyte and lym-
phocyte counts. Hospital acquisition of bacteraemia and
bacteraemia caused by Salmonella enterica serovar Enteri-
tidis and Group D Salmonella was notably higher in the
immunosuppressed patients although it was not statisti-
cally significant. In contrast, gastroenteritis, atheroscle-
rotic conditions and mycotic aneurysm were significantly
more common in the non-immunosuppressed patients.
The non-immunosuppressed group also had a higher pro-
portion of older patients (>50 years) with a significantly
higher median age (64 versus 36.5 years; p = 0.005). The
median length of hospitalization was longer in the non-
immunosuppressed group (10 days versus 8 days) possi-
bly related to increased early mortality in the severely
immunosuppressed group, although it was statistically
not significant.
Discussion
NTS is increasingly recognized as an important pathogen
associated with bacteraemia in both the immunosup-
pressed as well as the immunocompetent patients. In the
present study, serogroup D had the highest blood inva-
siveness with 40 out of the 43 (93%) serogroup D isolates
belonging to Salmonella enterica serovar Enteritidis. Salmo-
nella enterica serovar Typhimurium [3], the most common
serotype isolated in Malawi was not noted in any of our
bacteraemic patients. Taiwan demonstrates a high preva-
lence of serogroup B and C [10] and Thailand has a higher
proportion of serogroup C [2] amongst their bacteraemic
patients. The knowledge about the prevalent serotypes
with high invasive potential is of epidemiological and
public health importance.
The extra-intestinal focus of infection (EFI) rate of 30.9%
in our study was higher than that reported by Galofre J et
al. [11]. However, EFI rates of as high as 47% have been
reported in Taiwan involving patients with Salmonella
enterica serovar Choleraesuis bacteraemia [12]. Contrary
to previous studies which found higher percentage
mycotic aneurysms amongst their NTS bacteraemic
patients [12,13], our study had significantly lower rates;
an overall rate of 5.5% which increased to 17% amongst
patients > 50 years (P = 0.031). The risk factors for vascu-
lar infection in NTS bacteraemic patients which includes
age > 50 and underlying atherosclerosis [12,14] were
present in our patients and this serious complication
should always be kept in mind when an elderly patient
presents with NTS bacteraemia. The overall low rates of
mycotic aneurysm in the present study could be partly
Table 3: Comparison between NTS bacteraemia patients with or without severe immunosuppression
Variable Overall
n(%)/median(± IQR)
(n = 55)
Severe immunosuppression
n(%)/median (± IQR)
p OR 95%C1
Yes (n = 36) No(n = 19)
Age > 50 a 18(32.7) 6(16.7) 12(63.2) 0.001 0.12 0.03–0.42
Male b 37(67.3) 24(66.7) 13(68.4) 0.89 0.92 0.28–3.034
EF1 b 17(30.9) 10(27.8) 7(36.8) 0.49 0.66 0.20–2.15
Mycotic aneurysm a 3(5.5) 0(0) 3(15.8) 0.037 undefined
Gastroenteritis b 16(29.1) 7(19.4) 9(47.4) 0.03 0.27 0.079–0.91
Primary bacteraemia b 23(41.8) 19(52.8) 4 (21.1) 0.023 4.19 1.16–15.11
Atherosclerosis a 12(21.8) 4(11.1) 8(42.1) 0.015 0.17 0.043–0.69
Mortalitya 12(21.8) 11(30.6) 1(5.3) 0.041 7.92 0.94–66.97
Salmonella Enteritidis b 40(72.7) 29(80.6) 11(57.9) 0.073 3.013 0.88–10.30
Group D Salmonellaa 43(78.2) 31(86.1) 12(63.2) 0.084 3.62 0.96–13.64
Hospital acquisition a 10(18.2) 9(25.0) 1 (5.3) 0.14 6 0.70–51.53
Septic shock a 5(9.1) 4(11.1) 1(5.3) 0.65 2.25 0.23–21.69
Fever a 42(76.4) 27(75) 15(78.9) 1.00 1.25 0.33–4.76
Paediatric a 13(23.6) 10(27.8) 3(15.8) 0.51 0.49 0.12–2.04
Opportunistic infections a 11(20) 11(30.6) 0(0) 0.01 Undefined
Leukopenia b 15(27.3) 15(41.6) 0(0) 0.001 undefined
Blood culture positivity < 24 hours b 35(63.6) 24(66.7) 11(57.9) 0.52 1.45 0.46–4.57
Age (years) c 39(43.0) 36.5(31.25) 64.0(41.0) 0.005 NA
Duration of hospitalization (days) c 9(13.0) 8.0(16.0) 10.0(12.0) 0.18 NA
Leukocytes/mm3c 7.7(7.0) 5.5(7.18) 8.3(5.7) 0.016 NA
Lymphocytes/mm3 c 1.1(1.4) 0.9(1.0) 1.9(2.2) 0.026 NA
Duration of symptoms (days) c 5(4.0) 5.0(4.0) 5.0(4.0) 0.98 NA
a Fisher's exact test; b Chi-squared test; c Non-parametric Mann-Whitney test.
a and b expressed as number (%); c expressed as median (± IQR)
NA = not applicableAnnals of Clinical Microbiology and Antimicrobials 2009, 8:15 http://www.ann-clinmicrob.com/content/8/1/15
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attributed to very low prevalence of Salmonella enterica
serovar Choleraesuis bacteraemia, which has a high predi-
lection for causing bacteraemia and mycotic aneurysm
[12,13]. The presence of mycotic aneurysm and athero-
sclerotic conditions were significantly lower in the immu-
nosuppressed patients in this study (p < 0.05). Although
immunosuppression predisposes patients to bacteraemia,
it has a contradictory role in the pathogenesis of endovas-
cular infection [14], suggesting the possible role of
immune system in the process of inflammation and
destruction of aorta and heart valves.
In recent years, NTS bacteraemia has been increasingly
reported as a cause of life-threatening infection in immu-
nocompromised hosts. It is worth noting that, in our
study, malignancy and HIV/AIDS were the two most com-
mon conditions associated with NTS bacteraemia. As sug-
gested by several recent reports in Thailand and Malawi,
NTS bacteraemia has become increasingly important
amongst patients with HIV [2,15]. Multiple series have
identified malignancy as a risk factor for NTS bacteraemia
[14]. SLE was the predisposing disease in 10.9% of our
cases. In a recent series involving SLE bacteraemic patients
[16], NTS was the most common gram-negative bacteria
isolated. In the present study, significantly lower propor-
tion of patients >50 years had severe immunosuppressive
conditions like HIV and malignancy, instead they pre-
sented with age-related conditions like atherosclerosis.
The findings in the present study showed that the pres-
ence of primary bacteraemia and absence of gastroenteri-
tis was more common in patients with severe
immunosuppression and this concurred with the findings
of Ramos et al. [17]. Underlying immunosuppression
should be excluded in patients presenting with NTS
bacteraemia in the absence of gastroenteritis [17,18].
Although the overall mortality in the present study was
21.8% (12/55), 11 of the 12 deaths actually occurred in
patients with severe immunosuppressive diseases. There-
fore, in the present study the deaths were most likely
attributable to the underlying conditions. Variations in
mortality rates associated with NTS bacteraemia ranging
from 12% [11] to 47% [15] has been reported in previous
studies. These wide ranges may reflect the differences in
the severity of underlying diseases, the serovars of NTS,
the availability of antimicrobials and the antimicrobial
resistance of NTS in various countries.
A predisposition to NTS bacteraemia in immunosup-
pressed patients and a trend towards higher mortality
observed in patients with immunosuppressed conditions
illustrate the importance of immune system in defense
against Salmonella infection. Cell mediated immunity is
vital for defense against intracellular bacteria like Salmo-
nella and leukocytes especially lymphocytes are essential
host defense. In the present study, severely immunosup-
pressed patients presented with significantly lower lym-
phocyte counts. Cytokine deficiencies such as interleukin
IL-12/IL-23 and interferon gamma can predispose one to
invasive NTS infections [4,19]. Equally important is to
determine the virulence of Salmonella strains which may
favor systemic dissemination in the host. Direct inhibi-
tion of T lymphocyte activation, the interference of profes-
sional antigen presenting cells function to process and
present Salmonella-expressed antigens to T cell are some of
the immune evasion techniques to escape immune detec-
tion by virulent Salmonella. The elucidation of these viru-
lent factors will allow for the design of new strategies to
prevent the systemic diseases caused by this pathogen
[20].
A major limitation of the present study was that it was
based in a tertiary hospital and hence might be biased
towards patients with invasive NTS diseases. Moreover,
most patients attended local health clinics for diarrhoeal
diseases. Therefore, our data on blood invasiveness ratio
which is based on positive stool and blood isolates
obtained from the microbiology laboratory may not be
reflective of the true incidence. However, it provides a rel-
ative comparison between the different serovars. Sec-
ondly, owing to the retrospective nature of the study, the
presence of an extra-intestinal focus of infection could not
be verified for all patients. Thirdly, since our study was
conducted in a tertiary hospital where a high proportion
of patients are immunosupressed as a result of underlying
disease or modern aggressive therapy, similar results may
not be extrapolated to other institutions in Malaysia
where the patient population might differ.
Conclusion
In conclusion, serogroup D Salmonella had the highest
blood invasiveness and almost all these isolates belonged
to serotype Salmonella enterica serovar Enteritidis. Two-
third of patients had at least one severe immunosuppres-
sive condition with malignancy and HIV being the most
common. An extra-intestinal focus of infection was noted
in one third of patients, most commonly involving the
lung and soft tissue. Patients with severe clinical immuno-
suppression had higher mortality, presented more com-
monly with primary bacteraemia, leukopenia and
opportunistic infections and absence of gastroenteritis.
Early identification and prompt medical treatment can be
life saving because of the high mortality and morbidity
associated with this disease especially in the immunosup-
pressed patients.
Ethical approval
Ethical approval to review the data was obtained from
Clinical Research Centre, Penang General HospitalPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Annals of Clinical Microbiology and Antimicrobials 2009, 8:15 http://www.ann-clinmicrob.com/content/8/1/15
Page 7 of 7
(page number not for citation purposes)
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AD designed the study, collected, analyzed and inter-
preted the data and wrote the manuscript. QKF assisted in
analyzing the data and reviewed the manuscript.
Acknowledgements
The author acknowledges the laboratory staff at Department of Pathology, 
Penang General Hospital and Public Health Laboratory, Ipoh for serotyping 
the Salmonella isolates.
References
1. Hohmann EL: Nontyphoidal salmonellosis.  Clin Infect Dis 2001,
32:263-269.
2. Kiratisin P: Bacteraemia due to non-typhoidal Salmonella in
Thailand: clinical and microbiological analysis.  Trans R Soc Trop
Med Hyg 2008, 102:384-388.
3. Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E,
Zijlstra EE, Heyderman RS, Hart CA, Molyneux ME: Epidemics of
invasive Salmonella enterica serovarEnteritidis and S. enterica
serovar Typhimurium infection associated with multidrug
resistance among adults and children in Malawi.  Clin Infect Dis
2008, 46:963-969.
4. Gordon MA: Salmonella infections in immunocompromised
adults.  J Infect 2008, 56:413-422.
5. Weinberger M, Andorn N, Agmon V, Cohen D, Shohat T, Pitlik SD:
Blood invasiveness of Salmonella enterica as a function of age
and serotype.  Epidemiol Infect 2004, 132:1023-1028.
6. Ramos JM, García-Corbeira P, Aguado JM, Alés JM, Soriano F: Clas-
sifying extraintestinal non-typhoid Salmonella  infections.
QJM 1996, 89:123-126.
7. Farmer JJ III: Enterobacteriaceae: introduction and identifica-
tion.  In Manual of Clinical Microbiology Edited by: Murray PR, Baron
EJ, Pfaller MA, Tenover FC, Yolken RH. Washington DC, American
Society for Microbiology Press; 1995:438-449. 
8. Kauffmann F: Classification and nomenclature of the genus Sal-
monella.  Acta Pathol Microbiol Scand [B] Microbiol Immunol 1971,
79:421-422.
9. Clinical and Laboratory Standards Institute: Performance stand-
ards for antimicrobial susceptibility testing.  Fifteenth informa-
tional supplement. CLSI document M100-S15. Wayne, PA 2005.
10. Yen YF, Lin YC, Chen TL, Chen YY, Lin ML, Wang FD, Liu CY: Non-
typhoidal Salmonella bacteremia in adults.  J Microbiol Immunol
Infect 2007, 40:227-233.
11. Galofré J, Moreno A, Mensa J, Miró JM, Gatell JM, Almela M, Clara-
monte X, Lozano L, Trilla A, Mallolas J: Analysis of factors influ-
encing the outcome and development of septic metastasis or
relapse in Salmonella  bacteremia.  Clin Infect Dis 1994,
18:873-878.
12. Chen PL, Wu CJ, Chang CM, Lee HC, Lee NY, Shih HI, Lee CC, Ko
NY, Wang LR, Ko WC: Extra-intestinal focal infections in
adults with Salmonella enterica serotype Choleraesuis bacter-
aemia.  J Microbiol Immunol Infect 2007, 40:240-247.
13. Chen PL, Chang CM, Wu CJ, Ko NY, Lee NY, Lee HC, Shih HI, Lee
CC, Wang RR: Extraintestinal focal infections in adults with
nontyphoid  Salmonella  bacteraemia: predisposing factors
and clinical outcome.  J Intern Med 2007, 261:91-100.
14. Hsu RB, Lin FY: Risk factors for bacteraemia and endovascular
infection due to non-typhoid Salmonella: a reappraisal.  QJM
2005, 98:821-827.
15. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh
AL, Corkill JE, Hart CA, Gilks CF, Molyneux ME: Non-typhoidal sal-
monella bacteraemia among HIV-infected Malawian adults:
high mortality and frequent recrudescence.  AIDS 2002,
16:1633-1641.
16. Chen MJ, Tseng HM, Huang YL, Hsu WN, Yeh KW, Wu TL, See LC,
Huang JL: Long-term outcome and short-term survival of
patients with systemic lupus erythematosus after bacterae-
mia episodes: 6 year follow-up.  Rheumatology 2008,
47:1352-1357.
17. Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano
F: Clinical significance of primary vs. secondary bacteraemia
due to nontyphoidal Salmonella in patients without AIDS.
Clin Infect Dis 1994, 19:777-780.
18. Brown M, Eykyn SJ: Non-typhoidal  Salmonella  bacteraemia
without gastroenteritis: a marker of underlying immunosup-
pression. Review of cases at St. Thomas' Hospital 1970–1999.
J Infect 2000, 41:256-259.
19. MacLennan C, Fieschi C, Lammas DA, Picard C, Dorman SE, Sanal O,
MacLennan JM, Holland SM, Ottenhoff THM, Casanova JL, Kumarar-
atne D: Interleukin (IL)-12 and IL-23 are key cytokines for
immunity against Salmonella  in humans.  J Infect Dis 2004,
190:1755-1757.
20. Bueno SM, González PA, Schwebach JR, Kalergis AM: T cell immu-
nity evasion by virulent Salmonella enterica.  Immunol Lett 2007,
111:14-20.